This review describes methods and efforts that try to use clinic tumor histological specimen for tumor specific antibody generation by means of two powerful technologies: Laser capture microdissection (LCM) and phage display technology. The rationality of combining these two methods is stated and technological details are described. The design and practice of an in situ panning method is described and the potential clinical application discussed.
Loading....